Ulcerative Colitis Stocks List

Ulcerative Colitis Stocks Recent News

Date Stock Title
Apr 23 ABBV Allergan Aesthetics Invites Consumers to Be the Face of BOTOX® Cosmetic (onabotulinumtoxinA) and Their Other Biggest Brands
Apr 22 ABBV AbbVie (ABBV) to Report Q1 Earnings: What's in the Cards?
Apr 22 ABBV EU regulators approve Pfizer antibiotic Emblaveo
Apr 22 ABBV Buying the Dip in These 3 Undervalued Dividend Stocks
Apr 21 ABBV Can Magnificent 7 Help Script Market Turnaround? Earnings Pick Up Pace With Microsoft, Meta, Alphabet And Tesla Expected This Week
Apr 20 BHC 10 Best Healthcare Stocks to Buy Under $20
Apr 19 ABBV The Bad News Heading Into AbbVie's First-Quarter Earnings Report
Apr 19 ABBV Earnings Preview: AbbVie (ABBV) Q1 Earnings Expected to Decline
Apr 19 ABBV Pharma Stock Roundup: JNJ's Q1 Results, LLY, ABBV, RHHBY's Successful Study Data
Apr 18 ABBV Soon To Be Acquired Cerevel Therapeutics Reveals High Level Data From Late-Stage Parkinson's Disease Study
Apr 18 ABBV AbbVie Q1 Earnings Preview: No Repeat Of Last Year's Q1 Disappointment
Apr 18 ABBV Heard on the Street: AbbVie’s Bet on a Neuroscience Drug Maker Just Got Better
Apr 18 ABBV AbbVie succeeds in late-stage trial for Rinvoq in inflammatory condition
Apr 18 ABBV Phase 3 SELECT-GCA Study of Upadacitinib (RINVOQ®) Showed Positive Results in Patients With Giant Cell Arteritis
Apr 18 ABBV AbbVie buyout Cerevel posts late-stage win for Parkinson’s disease drug
Apr 18 ABBV Cerevel, in ‘major surprise,’ finds success in late-stage Parkinson’s study
Apr 17 ABBV AbbVie (ABBV) Increases Despite Market Slip: Here's What You Need to Know
Apr 17 ABBV CVS favors Humira copycats hurting AbbVie’s market share: Evercore
Ulcerative Colitis

Ulcerative colitis (UC) is a long-term condition that results in inflammation and ulcers of the colon and rectum. The primary symptoms of active disease are abdominal pain and diarrhea mixed with blood. Weight loss, fever, and anemia may also occur. Often, symptoms come on slowly and can range from mild to severe. Symptoms typically occur intermittently with periods of no symptoms between flares. Complications may include megacolon, inflammation of the eye, joints, or liver, and colon cancer.The cause of UC is unknown. Theories involve immune system dysfunction, genetics, changes in the normal gut bacteria, and environmental factors. Rates tend to be higher in the developed world with some proposing this to be the result of less exposure to intestinal infections, or to a Western diet and lifestyle. The removal of the appendix at an early age may be protective. Diagnosis is typically by colonoscopy with tissue biopsies. It is a kind of inflammatory bowel disease (IBD) along with Crohn's disease and microscopic colitis.Dietary changes, such as maintaining a high-calorie diet or lactose-free diet, may improve symptoms. Several medications are used to treat symptoms and bring about and maintain remission, including aminosalicylates such as mesalazine or sulfasalazine, steroids, immunosuppressants such as azathioprine, and biologic therapy. Removal of the colon by surgery may be necessary if the disease is severe, does not respond to treatment, or if complications such as colon cancer develop. Removal of the colon and rectum can cure the disease.Together with Crohn's disease, about 11.2 million people were affected as of 2015. Each year it newly occurs in 1 to 20 per 100,000 people, and 5 to 500 per 100,000 individuals are affected. The disease is more common in North America and Europe than other regions. Often it begins in people aged 15 to 30 years, or among those over 60. Males and females appear to be affected in equal proportions. It has also become more common since the 1950s. Together, ulcerative colitis and Crohn's disease affect about a million people in the United States. With appropriate treatment the risk of death appears the same as that of the general population. The first description of ulcerative colitis occurred around the 1850s.

Browse All Tags